ATE137403T1 - Zubereitung von liposomen- und lipid- komplexzusammensetzungen - Google Patents

Zubereitung von liposomen- und lipid- komplexzusammensetzungen

Info

Publication number
ATE137403T1
ATE137403T1 AT90906530T AT90906530T ATE137403T1 AT E137403 T1 ATE137403 T1 AT E137403T1 AT 90906530 T AT90906530 T AT 90906530T AT 90906530 T AT90906530 T AT 90906530T AT E137403 T1 ATE137403 T1 AT E137403T1
Authority
AT
Austria
Prior art keywords
liposome
compounds
aprotic solvent
preparation
lipid complex
Prior art date
Application number
AT90906530T
Other languages
English (en)
Inventor
Francis C Szoka Jr
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE137403T1 publication Critical patent/ATE137403T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90906530T 1989-03-31 1990-03-28 Zubereitung von liposomen- und lipid- komplexzusammensetzungen ATE137403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05

Publications (1)

Publication Number Publication Date
ATE137403T1 true ATE137403T1 (de) 1996-05-15

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906530T ATE137403T1 (de) 1989-03-31 1990-03-28 Zubereitung von liposomen- und lipid- komplexzusammensetzungen

Country Status (11)

Country Link
EP (1) EP0467954B1 (de)
JP (1) JP2798302B2 (de)
AT (1) ATE137403T1 (de)
AU (1) AU638245B2 (de)
CA (1) CA2050679C (de)
DE (1) DE69026820T2 (de)
DK (1) DK0467954T3 (de)
ES (1) ES2087151T3 (de)
HU (1) HU208070B (de)
NO (1) NO303205B1 (de)
WO (1) WO1990011780A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
JP3074734B2 (ja) 1990-11-16 2000-08-07 日本新薬株式会社 分散製剤
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
ATE199640T1 (de) 1993-07-08 2001-03-15 Liposome Co Inc Verfahren zum kontrollieren der liposomengrösse
DE69434623T2 (de) * 1993-09-29 2006-07-27 Dsm Ip Assets B.V. Modifizierte Formen des Natamycins, Verfahren zu ihrer Herstellung und sie enthaltende antifungale Zusammensetzungen
AU705549B2 (en) * 1995-06-07 1999-05-27 Promega Biosciences, Inc. Phosphonic acid-based cationic lipids
DE69924004T2 (de) * 1998-12-22 2006-02-09 United States Of America Represented By The Secretary, Department Of Health & Human Services Verabreichungssystem für wasserunlösliche arzneistoffe
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
EP1334718A4 (de) * 2000-10-26 2007-07-18 Senju Pharma Co Arzneimittelzusammensetzung mit einem dipeptydylaldehydderivat
EP1343476B1 (de) * 2000-12-01 2008-05-28 Biomira Inc. Herstellung grosser liposome durch infusion in peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
AU2008227852B2 (en) * 2007-03-19 2011-02-24 Fresenius Kabi Oncology Ltd. Proliposomal and liposomal compositions
CA2705797A1 (en) * 2007-11-14 2009-05-22 The Regents Of The University Of California Sterol-modified amphiphilic lipids
PL2344198T3 (pl) * 2008-09-27 2021-05-31 Jina Pharmaceuticals Inc. Preparaty farmaceutyczne na bazie lipidów do stosowania miejscowego
US20130338064A1 (en) * 2010-07-14 2013-12-19 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Insulin-lipid complex,preparation method therefor, and preparation thereof
AU2015301234A1 (en) 2014-08-04 2017-06-15 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into lipid vesicles
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関　則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
NO913816D0 (no) 1991-09-27
DK0467954T3 (da) 1996-05-28
HUT59818A (en) 1992-07-28
EP0467954B1 (de) 1996-05-01
HK1000912A1 (en) 1998-05-08
HU208070B (en) 1993-08-30
JPH04506207A (ja) 1992-10-29
WO1990011780A1 (en) 1990-10-18
CA2050679A1 (en) 1990-10-01
NO913816L (no) 1991-11-26
EP0467954A1 (de) 1992-01-29
JP2798302B2 (ja) 1998-09-17
HU903559D0 (en) 1991-12-30
DE69026820T2 (de) 1996-11-28
CA2050679C (en) 1998-09-22
NO303205B1 (no) 1998-06-15
EP0467954A4 (en) 1992-06-03
DE69026820D1 (de) 1996-06-05
AU638245B2 (en) 1993-06-24
AU5434590A (en) 1990-11-05
ES2087151T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
DE69026820D1 (de) Zubereitung von liposomen- und lipid-komplexzusammensetzungen
CA1262093C (en) STEROID LIPOSOMES
DE3867866D1 (de) Liposomzubereitung und ihre herstellung.
GR3020068T3 (en) Preparation of lipidic microparticles
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
NO172729C (no) Fremgangsmaate for fremstilling av en suspensjon av fosfolipidvesikler.
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
DE3482161D1 (de) Zubereitung von arzneimittelhaltigen lipidvesikeln und verfahren zu deren herstellung.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
NO174833C (no) Fremgangsmåte for fremstilling av et injiserbart preparat
EA200000765A1 (ru) Получение липидной смеси и фосфолипидная суспензия, содержащая липидную смесь
ES8600931A1 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
DK544883A (da) Stabile plurilamellare vesikler
RU2000124317A (ru) Эритропоэтиновая липосомальная дисперсия
EA200501285A1 (ru) Способ получения липосомальных препаратов
GR3017118T3 (en) Liposomal-polyene preliposomal powder and method for its preparation.
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
ES2060050T3 (es) Beta-tioacrilamidas s-sustituidas y su uso como microbicidas.
JPS5675438A (en) Method for stabilizing aqueous solution of cyanocobalamin
DE3851842D1 (de) Wässrige bereitung von liposomenzusammensetzungen.
ATE270093T1 (de) Schaumförmige zubereitungen mit einem gehalt an grenzflächenaktiven substanzen und elektrolyten
MY134714A (en) Release-controlled somatotropin composition and method for the preparation thereof
KR920002166A (ko) 주사용 리포좀 분산제를 제조하는 방법
JPS6431720A (en) Antihyperlipemic agent consisting of pyrimido(2,1-b)benzothiazole derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee